Print

Stemgent Betting $4.5 Million on Scottish Biotech  
3/3/2010 7:47:23 AM

Xconomy.com -- Stemgent, a provider of biological materials for life sciences research with offices in Cambridge, MA, and San Diego, reports this morning it will invest $4.5 million over the next three years in the Dundee, Scotland-based biotech firm Ubiquigent.
//-->